Cargando…
Donepezil-induced psychosis: a cautionary report of a rare adverse reaction
INTRODUCTION: Donepezil is an acetylcholinesterase inhibitor approved by the Food and Drug Administration for the treatment of dementia in Alzheimer’s disease. While it is not curative for Alzheimer’s disease, donepezil has been shown to improve symptoms and slow disease progression; however, cases...
Autores principales: | Hutchings, K. R., Hutchings, B. K., Ratnakaran, B., Kablinger, A. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434686/ http://dx.doi.org/10.1192/j.eurpsy.2023.778 |
Ejemplares similares
-
The Same Day on Repeat: A Unique Case of Persistent Déjà Vu Phenomenon as a Long COVID Symptom in an Older Adult
por: Jileaeva, I., et al.
Publicado: (2023) -
Revisiting hysterical psychosis: A case report
por: Barbosa, D., et al.
Publicado: (2021) -
Donepezil-induced QTc prolongation: A case report
por: Vogel, Samantha M., et al.
Publicado: (2019) -
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023) -
Is it psychosis? Heads or tails. A case report
por: Rodado León, B., et al.
Publicado: (2022)